Sacubitril/Valsartan Improves Autonomic Function and Cardiopulmonary Parameters in Patients with Heart Failure with Reduced Ejection Fraction

Background: Heart rate recovery (HRR) is a marker of vagal tone, which is a powerful predictor of mortality in patients with cardiovascular disease. Sacubitril/valsartan (S/V) is a treatment for heart failure with reduced ejection fraction (HFrEF), which impressively impacts cardiovascular outcome....

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Clin Med
Hlavní autoři: Giallauria, Francesco, Vitale, Giuseppe, Pacileo, Mario, Di Lorenzo, Anna, Oliviero, Alessandro, Passaro, Francesco, Calce, Roberta, Parlato, Alessandro, Testa, Crescenzo, D’Ambrosio, Giuseppe, Romano, Giuseppe, Clemenza, Francesco, Sarullo, Silvia, Venturini, Elio, Gentile, Marco, Nugara, Cinzia, Iannuzzo, Gabriella, D’Andrea, Antonello, Vigorito, Carlo, Sarullo, Filippo M.
Médium: Artigo
Jazyk:Inglês
Vydáno: MDPI 2020
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7356720/
https://ncbi.nlm.nih.gov/pubmed/32560431
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm9061897
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky